Pier 88 Investment Partners’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $838K | Buy |
244,180
+390
| +0.2% | +$1.34K | 0.16% | 58 |
|
|
2025
Q1 | $544K | Buy |
243,790
+6,890
| +3% | +$15.4K | 0.1% | 83 |
|
|
2024
Q4 | $694K | Buy |
236,900
+41,400
| +21% | +$121K | 0.14% | 62 |
|
|
2024
Q3 | $508K | Buy |
195,500
+33,880
| +21% | +$88.1K | 0.11% | 71 |
|
|
2024
Q2 | $478K | Buy |
161,620
+126,640
| +362% | +$375K | 0.11% | 79 |
|
|
2024
Q1 | $158K | Buy |
+34,980
| New | +$158K | 0.04% | 93 |
|